We don't really know details of the protocol - it is possible that several pre-determined analyses were to have been done that will be consider prospective. We won't know until they release the full data set and analysis.
Not sure what you mean by "single group assignment". The trial design clearly had two treated arms plus placebo, allowing for subgroup TLD reporting if desired.
Market Data 
Markets 
AI
